• 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
RU Russia
Stand No: 62B31
BIOCAD is fully integrated pharmaceutical company, excels at full-cycle drug discovery and development, large-scale manufacturing of therapeutics for the treatment cancer and autoimmune disorders. Having a number of mAb biosimilars on the market, BIOCAD has become a top manufacture of high value chemical APIs – glatiramer acetate, pemetrexed and others.
Sub-event: CPHI
GB United Kingdom
Stand No: 90C01
Pharmagona is a fast-growing company in the emerging market for "Biosimilars" providing solutions to address the evolving needs of patients suffering from life-threatening diseases all over the world to improve the patient's quality of life. Pharmagona is actively involved in R&D, manufacturing and sales of recombinant proteins and monoclonal antibodies.
IN India
Stand No: 101B79
Serum Institute of India Pvt Ltd (SIIPL) is the world's largest vaccine manufacturer by number of doses produced. We are ranked as India's No. 1 biotechnology company, manufacturing highly specialized vaccines. It is estimated that about 65% of the children in the world receive at least one vaccine manufactured by SIIPL. Vaccines manufactured by us are being used in more than 170 countries across the globe. 25 vaccines manufactured by SIIPL are pre-qualified by WHO for supply to UN agencies & we are the major supplier of vaccines to UNICEF and PAHO. SIIPL is actively associated with international agencies like WHO, PATH, NIBSC/HPA, Bill & Melinda Gates Foundation, CBER, Aktiv-Dry/Colorado University, EDQM, RIVM/NVI, NIH/CDC, Rhein Biotech, USAID, University of Massachusetts among others.
IN India
Stand No: 40F43
Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is India's largest Contract Research Organization offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. Our service offerings in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates (“ADC”) and oligonucleotides. Our integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage. We are also in the process of setting up a large scale manufacturing facility at Mangalore to strengthen our commercial manufacturing services. Syngene brings together a state-of-the-art infrastructure spread across 1.3 Mn sq. ft. and a highly experienced team...